113 related articles for article (PubMed ID: 35930955)
1. Refined efficacy and outcome estimates of surgical treatment in oldest-old patients with glioblastomas based on competing risk model and conditional survival analysis: A surveillance, epidemiology, and end results population-based study.
Zhao L; Gong K
Clin Neurol Neurosurg; 2022 Oct; 221():107391. PubMed ID: 35930955
[TBL] [Abstract][Full Text] [Related]
2. Conditional Survival Analysis for Spinal Chondrosarcoma Patients After Surgical Resection.
Song K; Lin K; Guan H; Li F
Spine (Phila Pa 1976); 2020 Aug; 45(16):1110-1117. PubMed ID: 32205690
[TBL] [Abstract][Full Text] [Related]
3. Evaluating extent of resection in pediatric glioblastoma: a multiple propensity score-adjusted population-based analysis.
Adams H; Adams HH; Jackson C; Rincon-Torroella J; Jallo GI; Quiñones-Hinojosa A
Childs Nerv Syst; 2016 Mar; 32(3):493-503. PubMed ID: 26767842
[TBL] [Abstract][Full Text] [Related]
4. Interaction Between the Contributions of Tumor Location, Tumor Grade, and Patient Age to the Survival Benefit Associated with Gross Total Resection.
Carroll KT; Bryant AK; Hirshman B; Alattar AA; Joshi R; Gabel B; Carter BS; Harismendy O; Vaida F; Chen CC
World Neurosurg; 2018 Mar; 111():e790-e798. PubMed ID: 29309983
[TBL] [Abstract][Full Text] [Related]
5. Glioblastoma in the elderly: the effect of aggressive and modern therapies on survival.
Babu R; Komisarow JM; Agarwal VJ; Rahimpour S; Iyer A; Britt D; Karikari IO; Grossi PM; Thomas S; Friedman AH; Adamson C
J Neurosurg; 2016 Apr; 124(4):998-1007. PubMed ID: 26452121
[TBL] [Abstract][Full Text] [Related]
6. Management and Outcomes in the Oldest-Old Population with Glioblastoma.
Moraes FY; Lo A; Morgan ER; Millar BA; Shultz DB; Maurice C; Harlos C; Kongkham P; Bernstein M; Zadeh G; Laperriere N; Mason W; Berlin A
Can J Neurol Sci; 2018 Mar; 45(2):199-205. PubMed ID: 29249210
[TBL] [Abstract][Full Text] [Related]
7. Superior Efficacy of Gross Total Resection in Anaplastic Astrocytoma Patients Relative to Glioblastoma Patients.
Padwal JA; Dong X; Hirshman BR; Hoi-Sang U; Carter BS; Chen CC
World Neurosurg; 2016 Jun; 90():186-193. PubMed ID: 26924115
[TBL] [Abstract][Full Text] [Related]
8. Effect of Gross Total Resection in World Health Organization Grade II Astrocytomas: SEER-Based Survival Analysis.
Schupper AJ; Hirshman BR; Carroll KT; Ali MA; Carter BS; Chen CC
World Neurosurg; 2017 Jul; 103():741-747. PubMed ID: 28419878
[TBL] [Abstract][Full Text] [Related]
9. Multiple craniotomies in the management of multifocal and multicentric glioblastoma. Clinical article.
Hassaneen W; Levine NB; Suki D; Salaskar AL; de Moura Lima A; McCutcheon IE; Prabhu SS; Lang FF; DeMonte F; Rao G; Weinberg JS; Wildrick DM; Aldape KD; Sawaya R
J Neurosurg; 2011 Mar; 114(3):576-84. PubMed ID: 20690813
[TBL] [Abstract][Full Text] [Related]
10. Gross-total resection outcomes in an elderly population with glioblastoma: a SEER-based analysis.
Noorbakhsh A; Tang JA; Marcus LP; McCutcheon B; Gonda DD; Schallhorn CS; Talamini MA; Chang DC; Carter BS; Chen CC
J Neurosurg; 2014 Jan; 120(1):31-9. PubMed ID: 24205904
[TBL] [Abstract][Full Text] [Related]
11. Selection of eligible patients with supratentorial glioblastoma multiforme for gross total resection.
Shinoda J; Sakai N; Murase S; Yano H; Matsuhisa T; Funakoshi T
J Neurooncol; 2001 Apr; 52(2):161-71. PubMed ID: 11508816
[TBL] [Abstract][Full Text] [Related]
12. Determining the role of adjuvant radiotherapy in the management of meningioma: a Surveillance, Epidemiology, and End Results analysis.
Reddy AK; Ryoo JS; Denyer S; McGuire LS; Mehta AI
Neurosurg Focus; 2019 Jun; 46(6):E3. PubMed ID: 31153148
[TBL] [Abstract][Full Text] [Related]
13. What Are the Conditional Survival and Functional Outcomes After Surgical Treatment of 115 Patients With Sacral Chordoma?
Ji T; Guo W; Yang R; Tang X; Wang Y; Huang L
Clin Orthop Relat Res; 2017 Mar; 475(3):620-630. PubMed ID: 26975382
[TBL] [Abstract][Full Text] [Related]
14. Clinical benefit from resection of recurrent glioblastomas: results of a multicenter study including 503 patients with recurrent glioblastomas undergoing surgical resection.
Ringel F; Pape H; Sabel M; Krex D; Bock HC; Misch M; Weyerbrock A; Westermaier T; Senft C; Schucht P; Meyer B; Simon M;
Neuro Oncol; 2016 Jan; 18(1):96-104. PubMed ID: 26243790
[TBL] [Abstract][Full Text] [Related]
15. Oligodendroglioma resection: a Surveillance, Epidemiology, and End Results (SEER) analysis.
Alattar AA; Brandel MG; Hirshman BR; Dong X; Carroll KT; Ali MA; Carter BS; Chen CC
J Neurosurg; 2018 Apr; 128(4):1076-1083. PubMed ID: 28498059
[TBL] [Abstract][Full Text] [Related]
16. Comparison of survival between cerebellar and supratentorial glioblastoma patients: surveillance, epidemiology, and end results (SEER) analysis.
Jeswani S; Nuño M; Folkerts V; Mukherjee D; Black KL; Patil CG
Neurosurgery; 2013 Aug; 73(2):240-6; discussion 246; quiz 246. PubMed ID: 23615082
[TBL] [Abstract][Full Text] [Related]
17. Long-term results of carmustine wafer implantation for newly diagnosed glioblastomas: a controlled propensity-matched analysis of a French multicenter cohort.
Pallud J; Audureau E; Noel G; Corns R; Lechapt-Zalcman E; Duntze J; Pavlov V; Guyotat J; Hieu PD; Le Reste PJ; Faillot T; Litre CF; Desse N; Petit A; Emery E; Voirin J; Peltier J; Caire F; Vignes JR; Barat JL; Langlois O; Dezamis E; Parraga E; Zanello M; Nader E; Lefranc M; Bauchet L; Devaux B; Menei P; Metellus P;
Neuro Oncol; 2015 Dec; 17(12):1609-19. PubMed ID: 26185110
[TBL] [Abstract][Full Text] [Related]
18. Long-term therapy with temozolomide is a feasible option for newly diagnosed glioblastoma: a single-institution experience with as many as 101 temozolomide cycles.
Barbagallo GM; Paratore S; Caltabiano R; Palmucci S; Parra HS; Privitera G; Motta F; Lanzafame S; Scaglione G; Longo A; Albanese V; Certo F
Neurosurg Focus; 2014 Dec; 37(6):E4. PubMed ID: 25434389
[TBL] [Abstract][Full Text] [Related]
19. [Analysis on risk factors of the degree of radical resection and prognosis of patients with locally recurrent rectal cancer].
Zhang JL; Wu T; Chen GW; Wang PY; Jiang Y; Tang JQ; Wu YC; Pan YS; Liu YC; Wan YL; Wang X
Zhonghua Wei Chang Wai Ke Za Zhi; 2020 May; 23(5):472-479. PubMed ID: 32842427
[No Abstract] [Full Text] [Related]
20. Quantitative imaging study of extent of surgical resection and prognosis of malignant astrocytomas.
Kowalczuk A; Macdonald RL; Amidei C; Dohrmann G; Erickson RK; Hekmatpanah J; Krauss S; Krishnasamy S; Masters G; Mullan SF; Mundt AJ; Sweeney P; Vokes EE; Weir BK; Wollman RL
Neurosurgery; 1997 Nov; 41(5):1028-36; discussion 1036-8. PubMed ID: 9361056
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
